carbamazepine brands

13 registered brands containing carbamazepine in Zimbabwe.

Carbamazepine 2D chemical structure

2D structure

Carbamazepine

PubChem CID 2554

Molecular formula: C15H12N2O

Carbamazepine's mechanism of action is not fully elucidated and is widely debated. One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves. In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms. A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes. A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation. Anticonvulsant: Exact mechanism unknown; may act postsynaptically by limiting the ability of neurons to sustain high frequency repetitive firing of action potentials through enhancement of sodium channel inactivation; in addition to altering neuronal excitability, may act presynaptically to block the release of neurotransmitter by blocking presynaptic sodium channels and the firing of action potentials, which in turn decreases synaptic transmission. Antineuralgic: Exact mechanism unknown; may involve gamma-aminobutyric acid (GABAB) receptors, which may be linked to calcium channels. Antimanic; antipsychotic: Exact mechanism is unknown; may be related to either the anticonvulsant or the antineuralgic effects of carbamazepine, or to tis effects on neurotransmitter modulator systems. Antidiuretic: Exact mechanism unknown; may exert a hypothalamic effect on the osmoreceptors mediated via secretion of antidiuretic hormone (ADH), or may have a direct effect on the renal tubule. For more Mechanism of Action (Complete) data for CARBAMAZEPINE (8 total), please visit the HSDB record page.

Source: PubChem (NCBI) ยท compound 2554

Product Manufacturer Status Country
APO-CARBAMAZEPINE
TABLET; ORAL
Apotex PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
CARBA 400-ER
TABLET; ORAL
Inventia Healthcare PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
CARBAMAZEPINE
TABLET; ORAL
Medicamen Biotech PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
CARBAMAZEPINE
TABLET; ORAL
Caps PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
CARBAMAZEPINE 200MG
TABLET; ORAL
Inventia Healthcare PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) Zimbabwe
EPICARB
TABLET; ORAL
Datlabs PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) Zimbabwe
NONE
TABLET; ORAL
Medreich PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) Zimbabwe
NONE
TABLET; ORAL
Medreich PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
TEGRETOL
TABLET; ORAL
Novartis PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
TEGRETOL 2%
SYRUP; ORAL
Delpharm PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
TEGRETOL CR
TABLET, COATED; ORAL
Novartis Farma PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe
TEGRETOL CR 400
TABLET, COATED; ORAL
Novartis Pharma PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) Zimbabwe
TORBAREC-200
TABLET; ORAL
Torrent Pharmaceuticals PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) Zimbabwe